PHONE
+44-7482-878921
+44-7482-878921
2376-0249
Clinical-Medical Image - International Journal of Clinical & Medical Images (2024) Volume 11, Issue 11
Author(s): Caroline Dubertret*
Department of Nutritional Sciences, Polytechnic Institute of Paris, Palaiseau, France
Received Date: April 02, 2018; Accepted Date: May 30, 2018; Published Date: June 06, 2018
Citation: Dubertret C. (2024) The Role of Artificial Intelligence in Early Detection and Molecular Classification of Head and Neck Skin Cancers: A Multidisciplinary Perspective. Int J Clin Med Imaging 11: 990.
Copyright: © 2024 Dubertret C. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Artificial intelligence is transforming healthcare, particularly in the diagnosis and classification of cancers. Head and neck skin cancers, which encompass a variety of malignancies with distinct molecular profiles, demand accurate and timely detection for effective treatment. AI, with its advanced computational capabilities, has emerged as a crucial tool in enhancing early diagnosis and enabling precise molecular classification of these cancers. AI algorithms, particularly those leveraging deep learning, are capable of analyzing vast amounts of data from clinical images, histopathological slides, and molecular assays with unprecedented speed and accuracy. By identifying subtle patterns and anomalies often missed by human evaluation, these systems can facilitate early detection, leading to better prognostic outcomes. Moreover, AI-driven models have shown promise in distinguishing between different molecular subtypes of skin cancers, which is vital for personalizing treatment strategies.
The multidisciplinary approach combines expertise from fields such as oncology, pathology, bioinformatics, and radiology, integrating AI technologies into clinical workflows. This collaboration ensures that AI tools are developed and utilized effectively, addressing real-world challenges in cancer diagnosis. For instance, AI applications in dermoscopy and radiology have shown remarkable accuracy in identifying malignant lesions, while machine learning models are increasingly being employed to analyze genetic and molecular data, providing insights into tumor behavior and potential therapeutic targets.
Despite its potential, the integration of AI in clinical practice faces challenges, including data standardization, algorithm interpretability, and ethical concerns. However, ongoing research and collaborative efforts are paving the way for AI to become an indispensable component of cancer care. By enhancing diagnostic accuracy and enabling molecular-level insights, AI holds the promise of revolutionizing the management of head and neck skin cancers, ultimately improving patient outcomes through earlier intervention and tailored treatments [1,2].
Multidisciplinary Approach; Personalized Treatment; Prognostic Outcomes
None.
None.
[1] Vrahatis AG, Skolariki K, Krokidis MG, Lazaros K and Exarchos TP, et al. “Revolutionizing the early detection of Alzheimer’s disease through non-invasive biomarkers: the role of artificial intelligence and deep learning.”Sens 23(9) 4184.
Google Scholar, Crossref, Indexed at
[2] Jones OT, Matin RN, Van der Schaar M, Bhayankaram KP and Ranmuthu CKI, et al. (2022). Artificial intelligence and machine learning algorithms for early detection of skin cancer in community and primary care settings: A systematic review.Lancet Digit Health 4(6) e466-e476.
Awards Nomination
